105
Views
10
CrossRef citations to date
0
Altmetric
Drug Profile

Cetuximab plus oxaliplatin-based chemotherapy in the treatment of colorectal cancer

&
Pages 319-329 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Stefan K. Burgdorf, Hans J. Nielsen & Jacob Rosenberg. (2009) Immunotherapy in colorectal cancer. Scandinavian Journal of Gastroenterology 44:3, pages 261-268.
Read now

Articles from other publishers (9)

Monica Cavia-SaizPilar MuñizReyes De SantiagoMarta Herreros-VillanuevaCarlos Garcia-GironAna Sofia LopezMaria Jesus Coma-del Corral. (2012) Changes in the levels of thioredoxin and indoleamine-2,3-dioxygenase activity in plasma of patients with colorectal cancer treated with chemotherapy. Biochemistry and Cell Biology 90:2, pages 173-178.
Crossref
Rebekka Krumbach, Julia Schüler, Michael Hofmann, Torsten Giesemann, Heinz-Herbert Fiebig & Thomas Beckers. (2011) Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: Activation of MET as one mechanism for drug resistance. European Journal of Cancer 47:8, pages 1231-1243.
Crossref
Kazushi Suzuki, Toshio Kokuryo, Takeshi Senga, Yukihiro Yokoyama, Masato Nagino & Michinari Hamaguchi. (2010) Novel combination treatment for colorectal cancer using Nek2 siRNA and cisplatin. Cancer Science 101:5, pages 1163-1169.
Crossref
Chin-Shaw Stella Tsai, Hung-Chang Chen, Jai-Nien Tung, Shung-Sheng Tsou, Tang-Yi Tsao, Ching-Fong Liao, Ying-Chun Chen, Chi-Yuan Yeh, Kun-Tu Yeh & Ming-Chung Jiang. (2010) Serum Cellular Apoptosis Susceptibility Protein Is a Potential Prognostic Marker for Metastatic Colorectal Cancer. The American Journal of Pathology 176:4, pages 1619-1628.
Crossref
David J. Matthews & Mary E. Gerritsen. 2010. Targeting Protein Kinases for Cancer Therapy. Targeting Protein Kinases for Cancer Therapy 435 525 .
Justin M Balko & Esther P Black. (2009) A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer. BMC Cancer 9:1.
Crossref
Konstantinos KonstantopoulosSusan N. Thomas. (2009) Cancer Cells in Transit: The Vascular Interactions of Tumor Cells. Annual Review of Biomedical Engineering 11:1, pages 177-202.
Crossref
Friederike Marquardt, Franz Rödel, Gianni Capalbo, Christian Weiss & Claus Rödel. (2009) Molecular targeted treatment and radiation therapy for rectal cancerMolekular-zielgerichtete Therapie und Bestrahlung zur Behandlung des Rektumkarzinoms. Strahlentherapie und Onkologie 185:6, pages 371-378.
Crossref
Belinda Sánchez Ramírez, Yeranddy Aguiar Alpízar, Diana Rosa Hernández Fernández, Greta Garrido Hidalgo, Ailem Rabasa Capote, Rolando Pérez Rodríguez & Luis Enrique Fernández. (2008) Anti-EGFR activation, anti-proliferative and pro-apoptotic effects of polyclonal antibodies induced by EGFR-based cancer vaccine. Vaccine 26:38, pages 4918-4926.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.